The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).
 
Ruben A. Mesa
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Celgene; CTI; Gilead Sciences; Incyte
 
Miklos Egyed
No Relationships to Disclose
 
Anita Szoke
No Relationships to Disclose
 
Aleksandr Suvorov
No Relationships to Disclose
 
Andrew Perkins
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Jiri Mayer
Research Funding - CTI; Novartis
Travel, Accommodations, Expenses - Novartis
 
Peter Ganly
Stock and Other Ownership Interests - Medipix
Honoraria - Novartis
Travel, Accommodations, Expenses - Roche Pharma AG
 
Eric Jourdan
Consulting or Advisory Role - Sanofi
 
Harry C. Schouten
Honoraria - Alexion Pharmaceuticals; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Patrizia Tosi
No Relationships to Disclose
 
Charles Michael Farber
No Relationships to Disclose
 
Pierre Zachee
No Relationships to Disclose
 
Christof Scheid
No Relationships to Disclose
 
James P. Dean
Employment - CTI
Stock and Other Ownership Interests - CTI
 
Paul Cernohous
Employment - CTI
Stock and Other Ownership Interests - CTI
 
Jyoti Nangalia
No Relationships to Disclose
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Incyte; Novartis; Shire
Research Funding - AOP Orphan Pharmaceuticals; Novartis
 
Alessandro M. Vannucchi
Speakers' Bureau - Novartis; Shire
Research Funding - Novartis
 
Adam Mead
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Novartis
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Sanofi
Speakers' Bureau - Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Claire N. Harrison
Honoraria - Baxter; CTI; Novartis; Sanofi
Speakers' Bureau - Baxter; CTI; Novartis; Sanofi; Shire
Research Funding - Celgene; CTI; Gilead Sciences; Novartis; Sanofi
Travel, Accommodations, Expenses - Novartis